Posted on: 02 September, 2021
The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling.
Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people.
A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disorders, spinal.....
Read more
Category: Neuroscience and Pain Research, Research Excellence, World-leading technology
Posted on: 24 August, 2021
New research is set to revolutionise the diagnosis and treatment of whiplash injuries, one of the most common and challenging injuries following a non-catastrophic motor vehicle collision.
The longitudinal study, conducted over more than five years, involved researchers from the Kolling Institute along with scientists from Northwestern University, University of Colorado and Stanford University.
Clo.....
Read more
Category: Musculoskeletal Research, Research Excellence, World-leading technology
Posted on: 20 August, 2021
Dr Cindy Shu will have a key role in building commercial capabilities at the Kolling after receiving a fellowship from the REDI (Researcher Exchange and Development within Industry) program.
The program provides financial support to Australian and international medical technology and pharmaceutical companies to bring the best talent in-house to work on priority medical research projects.
Cindy is o.....
Read more
Category: Musculoskeletal Research, Research Excellence, World-leading technology
Posted on: 02 August, 2021
Researchers from the Kolling Institute will support an important, Australia-wide project to address the inappropriate use of medications in residential aged care.
The initiative, to be co-ordinated by Monash University’s Centre for Medicine Use and Safety, has been awarded $2 million through the Medical Research Future Fund.
It will see pharmacists embedded in residential aged care facilities.....
Read more
Category: Neuroscience and Pain Research, Research Excellence
Posted on: 29 July, 2021
Regeneus, a clinical-stage regenerative medicine company, has announced an exciting research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute.
The study will further explore the disease modifying effects of Progenza™ and assess its effect in modulating the inflammatory and immune responses in a pre-clinical mode.....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 23 July, 2021
New research has found that while the majority of Australian spinal surgeons expect large improvements from common spinal procedures, they say there is only poor quality scientific evidence demonstrating the effectiveness of surgery compared with non-surgical approaches like physiotherapy.
A team from the Kolling Institute’s Back Pain Research group and the University of Sydney surveyed aroun.....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 14 July, 2021
The Kolling Institute is stepping up its efforts to foster gender equity in the research sector, joining nearly a dozen leading health and medical research organisations as academic partners of Franklin Women for 2021.
Established in 2014, Franklin Women is a professional community dedicated to supporting the careers of women in the health and medical research industry.
While more women enter healt.....
Read more
Category: Research Excellence
Posted on: 12 July, 2021
Kolling researchers will drive a large, national research project to improve diagnostic rates for those with mitochondrial diseases and broaden treatment pathways.
A $3 million grant from the Medical Research Future Fund is being invested in the project, which will involve clinicians, researchers and diagnostic scientists from a host of organisations including the Kolling and the Murdoch Children&r.....
Read more
Category: Neuroscience and Pain Research, Research Excellence
Posted on: 24 June, 2021
Two Royal North Shore Hospital clinician researchers will play a key role in a national research project to improve the use of medications across the community.
Head of the Department of Clinical Pharmacology and Kolling researcher Professor Sarah Hilmer and Head of the Department of General Practice Associate Professor Fiona Robinson will help drive the project which has been awarded more than $2......
Read more
Category: Funding support, Research Excellence
Posted on: 22 June, 2021
Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll.
Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice and governa.....
Read more
Category: Awards, Cardiovascular and Renal Research, Research Excellence